418 related articles for article (PubMed ID: 11150482)
1. Immunohistochemical distribution of the receptor for advanced glycation end products in neurons and astrocytes in Alzheimer's disease.
Sasaki N; Toki S; Chowei H; Saito T; Nakano N; Hayashi Y; Takeuchi M; Makita Z
Brain Res; 2001 Jan; 888(2):256-262. PubMed ID: 11150482
[TBL] [Abstract][Full Text] [Related]
2. Increased expression of the receptor for advanced glycation end products in neurons and astrocytes in a triple transgenic mouse model of Alzheimer's disease.
Choi BR; Cho WH; Kim J; Lee HJ; Chung C; Jeon WK; Han JS
Exp Mol Med; 2014 Feb; 46(2):e75. PubMed ID: 24503708
[TBL] [Abstract][Full Text] [Related]
3. Preventing activation of receptor for advanced glycation endproducts in Alzheimer's disease.
Lue LF; Yan SD; Stern DM; Walker DG
Curr Drug Targets CNS Neurol Disord; 2005 Jun; 4(3):249-66. PubMed ID: 15975028
[TBL] [Abstract][Full Text] [Related]
4. Advanced glycation end products (AGE) and their receptor (RAGE) in the brain of patients with Creutzfeldt-Jakob disease with prion plaques.
Sasaki N; Takeuchi M; Chowei H; Kikuchi S; Hayashi Y; Nakano N; Ikeda H; Yamagishi S; Kitamoto T; Saito T; Makita Z
Neurosci Lett; 2002 Jun; 326(2):117-20. PubMed ID: 12057842
[TBL] [Abstract][Full Text] [Related]
5. Reduced expression of endogenous secretory receptor for advanced glycation endproducts in hippocampal neurons of Alzheimer's disease brains.
Nozaki I; Watanabe T; Kawaguchi M; Akatsu H; Tsuneyama K; Yamamoto Y; Ohe K; Yonekura H; Yamada M; Yamamoto H
Arch Histol Cytol; 2007 Dec; 70(5):279-90. PubMed ID: 18431028
[TBL] [Abstract][Full Text] [Related]
6. RAGE is a key cellular target for Abeta-induced perturbation in Alzheimer's disease.
Yan SS; Chen D; Yan S; Guo L; Du H; Chen JX
Front Biosci (Schol Ed); 2012 Jan; 4(1):240-50. PubMed ID: 22202057
[TBL] [Abstract][Full Text] [Related]
7. AGE-RAGE stress: a changing landscape in pathology and treatment of Alzheimer's disease.
Prasad K
Mol Cell Biochem; 2019 Sep; 459(1-2):95-112. PubMed ID: 31079281
[TBL] [Abstract][Full Text] [Related]
8. Role of Aβ-receptor for advanced glycation endproducts interaction in oxidative stress and cytosolic phospholipase A₂ activation in astrocytes and cerebral endothelial cells.
Askarova S; Yang X; Sheng W; Sun GY; Lee JC
Neuroscience; 2011 Dec; 199():375-85. PubMed ID: 21978883
[TBL] [Abstract][Full Text] [Related]
9. RAGE-dependent signaling in microglia contributes to neuroinflammation, Abeta accumulation, and impaired learning/memory in a mouse model of Alzheimer's disease.
Fang F; Lue LF; Yan S; Xu H; Luddy JS; Chen D; Walker DG; Stern DM; Yan S; Schmidt AM; Chen JX; Yan SS
FASEB J; 2010 Apr; 24(4):1043-55. PubMed ID: 19906677
[TBL] [Abstract][Full Text] [Related]
10. Possible involvement of advanced glycation end-products (AGEs) in the pathogenesis of Alzheimer's disease.
Takeuchi M; Yamagishi S
Curr Pharm Des; 2008; 14(10):973-8. PubMed ID: 18473848
[TBL] [Abstract][Full Text] [Related]
11. Receptor for advanced glycation end products is upregulated in optic neuropathy of Alzheimer's disease.
Wang MY; Ross-Cisneros FN; Aggarwal D; Liang CY; Sadun AA
Acta Neuropathol; 2009 Sep; 118(3):381-9. PubMed ID: 19277685
[TBL] [Abstract][Full Text] [Related]
12. Expression of the receptor for advanced glycation end products in Huntington's disease caudate nucleus.
Ma L; Nicholson LF
Brain Res; 2004 Aug; 1018(1):10-7. PubMed ID: 15262199
[TBL] [Abstract][Full Text] [Related]
13. Glycation exacerbates the neuronal toxicity of β-amyloid.
Li XH; Du LL; Cheng XS; Jiang X; Zhang Y; Lv BL; Liu R; Wang JZ; Zhou XW
Cell Death Dis; 2013 Jun; 4(6):e673. PubMed ID: 23764854
[TBL] [Abstract][Full Text] [Related]
14. Site-specific blockade of RAGE-Vd prevents amyloid-beta oligomer neurotoxicity.
Sturchler E; Galichet A; Weibel M; Leclerc E; Heizmann CW
J Neurosci; 2008 May; 28(20):5149-58. PubMed ID: 18480271
[TBL] [Abstract][Full Text] [Related]
15. Involvement of microglial receptor for advanced glycation endproducts (RAGE) in Alzheimer's disease: identification of a cellular activation mechanism.
Lue LF; Walker DG; Brachova L; Beach TG; Rogers J; Schmidt AM; Stern DM; Yan SD
Exp Neurol; 2001 Sep; 171(1):29-45. PubMed ID: 11520119
[TBL] [Abstract][Full Text] [Related]
16. Advanced Glycation End Products Modulate Amyloidogenic APP Processing and Tau Phosphorylation: A Mechanistic Link between Glycation and the Development of Alzheimer's Disease.
Batkulwar K; Godbole R; Banarjee R; Kassaar O; Williams RJ; Kulkarni MJ
ACS Chem Neurosci; 2018 May; 9(5):988-1000. PubMed ID: 29384651
[TBL] [Abstract][Full Text] [Related]
17. RAGE: a potential target for Abeta-mediated cellular perturbation in Alzheimer's disease.
Chen X; Walker DG; Schmidt AM; Arancio O; Lue LF; Yan SD
Curr Mol Med; 2007 Dec; 7(8):735-42. PubMed ID: 18331231
[TBL] [Abstract][Full Text] [Related]
18. RAGE and Alzheimer's disease: a progression factor for amyloid-beta-induced cellular perturbation?
Yan SD; Bierhaus A; Nawroth PP; Stern DM
J Alzheimers Dis; 2009; 16(4):833-43. PubMed ID: 19387116
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical analysis of human brain suggests pathological synergism of Alzheimer's disease and diabetes mellitus.
Valente T; Gella A; Fernàndez-Busquets X; Unzeta M; Durany N
Neurobiol Dis; 2010 Jan; 37(1):67-76. PubMed ID: 19778613
[TBL] [Abstract][Full Text] [Related]
20. Aβ-AGE aggravates cognitive deficit in rats via RAGE pathway.
Chen C; Li XH; Tu Y; Sun HT; Liang HQ; Cheng SX; Zhang S
Neuroscience; 2014 Jan; 257():1-10. PubMed ID: 24188791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
